New developments in hereditary hemochromatosis

Citation
Vj. Felitti et E. Beutler, New developments in hereditary hemochromatosis, AM J MED SC, 318(4), 1999, pp. 257-268
Citations number
54
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
ISSN journal
00029629 → ACNP
Volume
318
Issue
4
Year of publication
1999
Pages
257 - 268
Database
ISI
SICI code
0002-9629(199910)318:4<257:NDIHH>2.0.ZU;2-S
Abstract
The iron content of the body is normally tightly controlled by regulation o f iron absorption. in hereditary hemochromatosis, mutation of an HLA class 1 gene, designated HFE, results in excessive iron absorption. Over many yea rs, accumulating iron produces tissue damage, most notably cirrhosis, cardi omyopathy, diabetes, and arthropathies. Hereditary hemochromatosis is the m ost common hereditary disease of Northern Europeans with a prevalence of ap proximately 5 per 1000. The most sensitive screening test for hemochromatos is is saturation of the transferrin with iron; a fasting value greater than 50% is strongly suggestive of the disease. Confirmation of increased iron storage can be achieved most readily by serial phlebotomy. We do not regard liver biopsy to be indicated, except in unusual circumstances. Early diagn osis and treatment by phlebotomy before tissue damage has occurred is essen tial, because life span seems to be normal in treated patients but markedly shortened in those who are not. Therefore, genetic counseling with evaluat ion of first-degree relatives is mandatory.